Detail akcie Avantor Rg online

Business Summary: Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Avantor Inc revenues decreased 3% to $6.55B. Net loss totaled $530.2M vs. income of $711.5M. Revenues reflect Laboratory Solutions segment decrease of 5% to $4.4B, Bioscience Production segment decrease of 1% to $2.15B, United States segment decrease of 8% to $3.28B. Net loss reflects Gain on sale of business increase from $446.6M (income) to $5.1M (expense).